integrichain products


Market Insights to Improve Patient Access at the Retail Pharmacy

Many factors challenge patients as they seek access to innovative brands at the retail pharmacy counter. Complicated payer policy restrictions, including prior authorizations and step edits that require a patient to first try generic alternatives, often delay treatment. Escalating out-of-pocket costs are another obstacle patients must navigate.

Life Sciences manufacturers invest a significant sum to guarantee patient access. Delivering a return on that investment is not possible unless brands can successfully execute pharmacy pull-through activities, help patients unwind a tangle of policy restrictions, and monitor payer compliance.

Actionable insights derived from multiple, enriched datasets give innovative retail brands the level of market intelligence to cost-effectively invest in patient access strategies to overcome today’s challenges. IntegriChain Retail Analytics breaks down market deciles, surfaces the payer/plan mix in each territory, measures performance against a competitive market basket, and provides store-level reporting on the frequency of prescription abandonment and rejection rates.

Distribution Solutions

retail analytics

Reduce Rx abandonment by identifying pharmacies serving patient populations at risk of delayed or blocked access to therapy

An Essential Information Asset for Targeting Retail Pull-Through Activities and Measuring Effectiveness

Over the past ten years, IntegriChain has led the industry’s efforts to analyze brand performance at the individual retail pharmacy. The IntegriChain Pharmacy enriched dataset illustrates which pharmacies are underperforming for a brand and which are important to a given category. Now, with new IntegriChain Retail Analytics, Brand and Trade teams can also understand the why’s—the underlying drivers—of retail pharmacy performance.

Enhance your Visibility into Your Pharmacy Campaigns

Retail Analytics super-boosts the insights delivered in our Pharmacy enriched dataset, IntegriChain’s competitive market deciles, and critical patient access data assets by adding key patient journey insights, including:

  • Formulary data showing the mix of patient lives by payer within the area of each pharmacy and the brand’s advantage or disadvantage, prior authorization requirements, and other controls such as step edits
  • Claims data showing the number of prescriptions lost in the area of each pharmacy due to benefit inquiry rejections, prior authorization rejections, or other reasons
  • Claims and co-pay card redemption data showing the sources of payment either in the pharmacy’s area or the specific pharmacy itself

With Retail Analytics, manufacturers can identify the specific pharmacies where a brand is performing or underperforming combined with the payer/plan, tier, out-of-pocket, and policy restriction context in the pharmacy’s surrounding patient population. This combination yields uniquely actionable insights that Brand, Trade, and Sales teams can turn into targeted, regionally-specific campaigns.

Retail Analytics Benefits

Accelerate Growth

Engage pharmacists on formulary wins to increase pull through at the pharmacies with impacted patient lives. 


Reduce Abandonment

Develop effective education strategies and campaigns for pharmacists who see the most Rxs with policy restrictions to mitigate formulary losses and coverage gaps. 


Protect Market Share

Identify which pharmacies fill the prescriptions for your existing patients along with each pharmacy’s rough payer mix to better protect your market share when a formulary loss occurs. 


Optimize Marketing Spend

Ensure co-pay cards are distributed to pharmacies with high rejection/reversal rates and high patient out-of-pocket costs


Reduce Marketing Risk

Identify co-pay program misuse in the pharmacy and educate the responsible pharmacists on appropriate use. 


adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71